Want to see SE:KLAR full AI Analyst Report?
Klaria Pharma Holding AB (KLAR) Stock Statistics & Valuation Metrics
Total Valuation
Klaria Pharma Holding AB has a market cap or net worth of SEK 132.58M. The enterprise value is SEK 195.31M.
- Market Cap
- SEK 132.58M
- Enterprise Value
- SEK 195.31M
Share Statistics
Klaria Pharma Holding AB has 245,976,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 245,976,150
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Klaria Pharma Holding AB’s return on equity (ROE) is 10.02 and return on invested capital (ROIC) is 625.94%.
- Return on Equity (ROE)
- 10.02
- Return on Assets (ROA)
- -0.95
- Return on Invested Capital (ROIC)
- 625.94%
- Return on Capital Employed (ROCE)
- 6.26
- Revenue Per Employee
- 2.25M
- Profits Per Employee
- -9.72M
- Employee Count
- 4
- Asset Turnover
- 0.22
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Klaria Pharma Holding AB is -3.13. Klaria Pharma Holding AB’s PEG ratio is -0.05.
- PE Ratio
- -3.13
- PS Ratio
- 1104.77
- PB Ratio
- -3.81
- Price to FCF
- -9.51
- Price to Operating Cash Flow
- -2.64
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, Klaria Pharma Holding AB had revenue of 9.00M and earned -38.90M in profits. Earnings per share was -0.21.
- Revenue
- 9.00M
- Gross Profit
- -2.23M
- Operating Income
- -20.42M
- Pretax Income
- -47.06M
- Net Income
- -38.90M
- EBITDA
- -9.20M
- Earnings Per Share (EPS)
- -0.21
Cash Flow
In the last 12 months, operating cash flow was -48.51M and capital expenditures 35.04M, giving a free cash flow of -13.48M billion.
- Operating Cash Flow
- -48.51M
- Free Cash Flow
- -13.48M
- Free Cash Flow per Share
- -0.05
Dividends & Yields
Klaria Pharma Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.52%
- Earnings Yield
- -30.22%
Stock Price Statistics
- Beta
- 1.81
- 52-Week Price Change
- 6.98%
- 50-Day Moving Average
- 0.63
- 200-Day Moving Average
- 0.81
- Relative Strength Index (RSI)
- 41.22
- Average Volume (3m)
- 910.48K
Important Dates
Klaria Pharma Holding AB upcoming earnings date is Nov 26, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- Nov 26, 2026
- Ex-Dividend Date
- ―
Financial Position
Klaria Pharma Holding AB as a current ratio of 0.05, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.05
- Quick Ratio
- 0.05
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.04
- Interest Coverage Ratio
- -1.49
Taxes
In the past 12 months, Klaria Pharma Holding AB has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Klaria Pharma Holding AB EV to EBITDA ratio is -5.58, with an EV/FCF ratio of -9.60.
- EV to Sales
- 1115.39
- EV to EBITDA
- -5.58
- EV to Free Cash Flow
- -9.60
- EV to Operating Cash Flow
- -2.67
Balance Sheet
Klaria Pharma Holding AB has SEK 8.47M in cash and marketable securities with SEK 9.70M in debt, giving a net cash position of -SEK 1.23M billion.
- Cash & Marketable Securities
- SEK 8.47M
- Total Debt
- SEK 9.70M
- Net Cash
- -SEK 1.23M
- Net Cash Per Share
- -SEK 0.01
- Tangible Book Value Per Share
- -SEK 0.24
Margins
Gross margin is 2449.14%, with operating margin of -27270.69%, and net profit margin of -33389.66%.
- Gross Margin
- 2449.14%
- Operating Margin
- -27270.69%
- Pretax Margin
- -33378.45%
- Net Profit Margin
- -33389.66%
- EBITDA Margin
- -20000.86%
- EBIT Margin
- -27270.69%
Analyst Forecast
The average price target for Klaria Pharma Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -99.01%
- EPS Growth Forecast
- 38.00%
Scores
- Smart Score
- ―
- AI Score
- 41
